Treace Medical Concepts will highlight new technology innovations and three-year interim ALIGN3D clinical results at the 2024 American College of Foot and Ankle Surgeons Annual Scientific Conference in Tampa, Florida from February 1-4, 2024. Treace will feature its current and next-generation technologies at its ACFAS exhibit booth and host Lapiplasty and Adductoplasty surgeon training events featuring recent innovations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TMCI:
- Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
- Treace Medical sees Q4 revenue $61.8M-$62.2M, consensus $58.89M.
- Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
- Treace Medical price target raised to $16 from $12 at Truist
- Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
